Regeneron alert: bragar eagel & squire, p.c. is investigating regeneron pharmaceuticals, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york, jan. 28, 2025 (globe newswire) -- bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against regeneron pharmaceuticals, inc. (nasdaq:regn) on behalf of long-term stockholders following a class action complaint that was filed against regeneron on january 7, 2025 with a class period from november 2, 2023 to october 30, 2024. our investigation concerns whether the board of directors of regeneron have breached their fiduciary duties to the company.
REGN Ratings Summary
REGN Quant Ranking